
    
      Primary endpoint:

        -  PSA progression rate, ASTRO guidelines.

      Secondary endpoints:

        -  PSA doubling time after progression

        -  Quality of Life (QoL)

        -  Safety

        -  Metastases free survival

        -  Overall survival
    
  